Download
s00392-020-01784-w.pdf 762,51KB
WeightNameValue
1000 Titel
  • PASCAL versus MitraClip-XTR edge-to-edge device for the treatment of tricuspid regurgitation: a propensity-matched analysis
1000 Autor/in
  1. Sugiura, Atsushi |
  2. Vogelhuber, Johanna |
  3. Öztürk, Can |
  4. Schwaibold, Zita |
  5. Reckers, David |
  6. Goto, Tadahiro |
  7. Kavsur, Refik |
  8. Becher, Marc Ulrich |
  9. Zimmer, Sebastian |
  10. Nickenig, Georg |
  11. Weber, Marcel |
1000 Erscheinungsjahr 2020
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2020-12-12
1000 Erschienen in
1000 Quellenangabe
  • 110(3):451-459
1000 Copyrightjahr
  • 2020
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00392-020-01784-w |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907034/ |
1000 Publikationsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • Background!#!Transcatheter tricuspid valve repair (TTVR) is a promising technique for the treatment of tricuspid regurgitation (TR). Data comparing the performance of novel edge-to-edge devices (PASCAL and MitraClip-XTR) are scarce.!##!Methods!#!We identified 80 consecutive patients who underwent TTVR using either the PASCAL or MitraClip-XTR system to treat symptomatic TR from July 2018 to June 2020. To adjust for baseline imbalances, we performed a propensity score (PS) 1:1 matching. The primary endpoint was a reduction in TR severity by at least one grade at 30 days.!##!Results!#!The PS-matched cohort (n = 44) was at high-surgical risk (EuroSCORE II: 7.5% [interquartile range (IQR) 4.8-12.1%]) with a mean TR grade of 4.3 ± 0.8 and median coaptation gap of 6.2 mm [IQR 3.2-9.1 mm]. The primary endpoint was similarly observed in both groups (PASCAL: 91% vs. MitraClip-XTR: 96%). Multiple device implantation was the most common form (59% vs. 82%, p = 0.19), and the occurrence of SLDA was comparable between the PASCAL and MitraClip-XTR system (5.7% [2 of 35 implanted devices] vs. 4.4% [2 of 45 implanted devices], p = 0.99). No periprocedural death or conversions to surgery occurred, and 30-day mortality (5.0% vs. 5.0%, log-rank p = 0.99) and 3-month mortality (10.0% vs. 5.0%, log-rank p = 0.56) were similar between both groups. During follow-up, functional NYHA class, 6-min walking distance, and health status improved in both groups.!##!Conclusions!#!Both TTVR devices, PASCAL and MitraClip-XTR, appeared feasible and comparable for an effective TR reduction. Randomized head-to-head comparisons will help to further define the appropriate scope of application of each system.
1000 Sacherschließung
lokal Female [MeSH]
lokal Follow-Up Studies [MeSH]
lokal Recovery of Function [MeSH]
lokal Transcathether
lokal Aged [MeSH]
lokal Tricuspid regurgitation
lokal Humans [MeSH]
lokal Prospective Studies [MeSH]
lokal Treatment Outcome [MeSH]
lokal MitraClip
lokal PASCAL
lokal Time Factors [MeSH]
lokal Tricuspid Valve Insufficiency/physiopathology [MeSH]
lokal Edge-to-edge
lokal Male [MeSH]
lokal Tricuspid Valve Insufficiency/surgery [MeSH]
lokal Propensity score matching
lokal Heart Valve Prosthesis Implantation/instrumentation [MeSH]
lokal Original Paper
lokal Tricuspid Valve Insufficiency/diagnosis [MeSH]
lokal Propensity Score [MeSH]
lokal Cardiac Catheterization/instrumentation [MeSH]
1000 Liste der Beteiligten
  1. https://orcid.org/0000-0002-9446-9963|https://frl.publisso.de/adhoc/uri/Vm9nZWxodWJlciwgSm9oYW5uYQ==|https://frl.publisso.de/adhoc/uri/w5Z6dMO8cmssIENhbg==|https://frl.publisso.de/adhoc/uri/U2Nod2FpYm9sZCwgWml0YQ==|https://frl.publisso.de/adhoc/uri/UmVja2VycywgRGF2aWQ=|https://frl.publisso.de/adhoc/uri/R290bywgVGFkYWhpcm8=|https://frl.publisso.de/adhoc/uri/S2F2c3VyLCBSZWZpaw==|https://frl.publisso.de/adhoc/uri/QmVjaGVyLCBNYXJjIFVscmljaA==|https://frl.publisso.de/adhoc/uri/WmltbWVyLCBTZWJhc3RpYW4=|https://frl.publisso.de/adhoc/uri/Tmlja2VuaWcsIEdlb3Jn|https://frl.publisso.de/adhoc/uri/V2ViZXIsIE1hcmNlbA==
1000 Hinweis
  • DeepGreen-ID: 22118209e118402d9fdb2284a187edb2 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Dateien
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6469988.rdf
1000 Erstellt am 2023-11-18T03:08:18.438+0100
1000 Erstellt von 322
1000 beschreibt frl:6469988
1000 Zuletzt bearbeitet Fri Dec 01 10:56:28 CET 2023
1000 Objekt bearb. Fri Dec 01 10:56:28 CET 2023
1000 Vgl. frl:6469988
1000 Oai Id
  1. oai:frl.publisso.de:frl:6469988 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source